APA (7th ed.) Citation

L, J., L, L., H, W., C, G., Z, Z., Z, Z., & H, Z. (2025). Early Elevation of Monocytic-to-Polymorphonuclear Myeloid-Derived Suppressor Cells Ratio in Critical Illness is Associated with Favorable Clinical Outcomes. Dove Medical Press.

Chicago Style (17th ed.) Citation

L, Jia, Long L, Wang H, Ge C, Zhang Z, Zhang Z, and Zhao H. Early Elevation of Monocytic-to-Polymorphonuclear Myeloid-Derived Suppressor Cells Ratio in Critical Illness Is Associated with Favorable Clinical Outcomes. Dove Medical Press, 2025.

MLA (9th ed.) Citation

L, Jia, et al. Early Elevation of Monocytic-to-Polymorphonuclear Myeloid-Derived Suppressor Cells Ratio in Critical Illness Is Associated with Favorable Clinical Outcomes. Dove Medical Press, 2025.